Talenthouse AG

Earnings Release • Aug 23, 2007

News Details

Ad-hoc | 23 August 2007 06:56

Quarterly Information as of 30 June 2007: Increase of NAV with 27.9% – Natoil extends the portfolio

NEW VALUE AG / Miscellaneous

Release of a Adhoc News, transmitted by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

Press release

Information regarding the first quarter of 2007 (as of 30 June 2007)

Increase of NAV with 27.9% – Natoil AG extends the portfolio

New Value, the SWX Swiss Exchange quoted Private Equity investment company,
which focuses on young growth companies, continued the expansion of its
portfolio in the first quarter of the business year 2007/08 and invested in
the young Swiss lubricant firm Natoil AG. Furthermore, New Value increased
its investment in the diagnostic company Swiss Medical Solution, where the
last tranche of the first financing round was closed. The stock price
closed 30 June 2007 on the SWX Swiss Exchange with CHF 18.00, the Net Asset
Value (NAV) amounted to CHF 25.47 per share and was thereby 27.9% higher
than at the end of the previous quarter (31.03.2007). The value of the
portfolio developed positively after the closing of the reporting period
and Net Asset Value was CHF 31.54 per share as of 15 August 2007.

During the reporting period, New Value invested in the young Swiss
lubricant company Natoil AG, Root LU. Natoil develops and sells industrial
lubricants, which possess superb technical properties. Thanks to low
friction loss their use allows substantial energy savings. The trend
towards higher energy prices and the current CO2-discussion underlines the
market potential of Natoil's lubricants, especially as their manufacture is
largely based on renewable resources. The new capital will be used for the
development of distribution channels and for further development of the
product portfolio.

The investment in the diagnostic company Swiss Medical Solution was
increased in June 2007. As part of the first financing round of overall CHF
2.5 Mio. agreed upon in June 2006, the last tranche of CHF 0.35 Mio. was
paid out in the form of a convertible loan. Currently, New Value, the other
shareholders and the management are in discussions as to a further
investment in the company development of Swiss Medical Solution. For
September 2007, investments are in preparation at the portfolio companies
Bogar und Mycosym International, in which New Value probably will
participate on a pro-rata basis to its current ownership stake.
Additionally, interesting companies in the domains medical technology,
software and renewable energy are under examination with the objective to
expand the portfolio further in the current business year.

Positive developments could also be reported from other New Value portfolio
companies: 3S Swiss Solar Systems reported a further expansion with the
acquisition of the company Belval from Neuchâtel, one of the globally
leading producers of testers for solar cells and modules. The 3S stock
price developed very positively and closed the reporting period with CHF
15.50 (CHF 8.20 per 31.03.2007; +98.8%). In July the course at times
increased to over CHF 30; it has however due to the turbulent financial
market been very volatile and was traded at CHF 24.00 when the stock
exchange closed yesterday. The Meyer Burger share developed in an equally
positive manner: The stock market price closed at 30 June 2007 with CHF 163
(CHF 82 per 31.03.2007; +89.0%), and increased thereafter even up to CHF
247.50. Also here there has been a marked correction during the last weeks
and the share was traded at CHF 217.50 the 15.08.2007. Both shares saw huge
demand during the last months, something which New Value used for profit
taking. Until the end of July 2007 around 15% of the position in 3S Swiss
Solar Systems and half of the shares held in Meyer Burger Technology were
divested.

Information about New Value AG

New Value, officially quoted at the SWX Swiss Exchange, invests directly in
private and rising companies from Switzerland or the rest of the
German-speaking region with above average market and growth potential. As
an investment company, New Value promotes innovative business models with
venture capital and accompanies these to market success. The portfolio
spans over companies of different maturity levels, starting with the market
introduction phase up to their establishment as medium-sized enterprises
with stable profits. A broad approach is consciously pursued. The portfolio
covers companies from the sectors renewable energy, medical technology,
health, information technology and new materials. New Value assigns great
value to ethical business concepts and good corporate governance while
selecting its portfolio companies. Criteria like meaningfulness, social
compatibility and ecological sustainability are considered by New Value as
decisive competition advantages, which affect and promote the quality of
the product and the service offering and thus, enable an above average
increase of value potential. Since the founding of New Value, EPS Value
Plus AG, Zurich, acts as investment advisor.

IR-Contact

New Value AG Tel.+41 43 344 38 38
Rolf Wägli Tel.+41 43 344 38 11, waegli@newvalue.ch
Peter Letter Tel.+41 43 344 38 18, letter@newvalue.ch

General Contact:
Marcel Rogenmoser, rogenmoser@newvalue.ch

23.08.2007 Financial News transmitted by DGAP

Language: English
Issuer: NEW VALUE AG
Bodmerstrasse 9
8027 Zürich
Schweiz
Phone: +41-43-344 38 38
Fax: +41-43-344 38 39
E-mail: info@newvalue.ch
Internet: www.newvalue.ch
ISIN: CH0010819867
WKN: 552932
Indices:
Listed: Freiverkehr in Berlin, München, Stuttgart, Düsseldorf; Open
Market in Frankfurt; Foreign Exchange(s) BX, SWX

End of News DGAP News-Service

---